AVITA MED LTD/S (AVMXY) Stock Price, News & Analysis

Company Overview

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.

Key Stats

• Today's Range: $7.89 to $7.89
• 50-Day Range: $7.89 to $7.89
• 52-Week Range: $1.06 to $8.58
• Volume: N/A
• Average Volume: 183,275 shs
• Market Capitalization: $651.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biological Products, Except Diagnostic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AVMXY
• CUSIP: N/A
• CIK: N/A
• Web: www.avitamedical.com
• Phone: 661-367-9170
• Fax: N/A
• Employees: 55
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.50
• Quick Ratio: 5.33

Sales & Book Value

• Annual Sales: $5.51 million
• Price / Sales: 118.31
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.26 per share
• Price / Book: 30.35

Miscellaneous

• Outstanding Shares: 82,620,000
• Free Float: N/A
• Market Cap: $651.87 million
• Optionable: Not Optionable
• Beta: 1.28